Interaction Checker

Choriogonadotropine alfa : interactions médicamenteuses

Choriogonadotropine alfa (Ovidrel) présente 60 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 37 de niveau majeur, 23 de niveau modéré, 0 de niveau mineur et 0 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

Interactions d'après la notice

Interactions majeures (37)

  • Acétazolamideinhibiteur de l'anhydrase carboniqueMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Acide étacryniquediurétique de l'anseMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Amiloridediurétique épargneur de potassiumMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Aténolol et chlortalidonebêtabloquantMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Bénazépril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Bisoprolol et hydrochlorothiazidebêtabloquantMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Bumétanidediurétique de l'anseMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Candésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Chlorothiazidediurétique thiazidiqueMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Chlortalidonediurétique thiazidiqueMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Énalapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Éplérénoneantagoniste de l'aldostéroneMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Fosinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Furosémidediurétique de l'anseMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Hydrochlorothiazidediurétique thiazidiqueMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Indapamidediurétique thiazidiqueMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Irbésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Lévothyroxinehormone thyroïdienneMajeure

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (notice Choriogonadotropine alfa, Contre-indications)

  • Lévothyroxine et liothyroninehormone thyroïdienneMajeure

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (notice Choriogonadotropine alfa, Contre-indications)

  • Liothyroninehormone thyroïdienneMajeure

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (notice Choriogonadotropine alfa, Contre-indications)

  • Lisinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Losartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Métolazonediurétique thiazidiqueMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Métoprolol et hydrochlorothiazidebêtabloquantMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Olmésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Olmésartan, amlodipine et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • PropylthiouracileantithyroïdienMajeure

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (notice Choriogonadotropine alfa, Contre-indications)

  • Quinapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Spironolactoneantagoniste de l'aldostéroneMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Spironolactone et hydrochlorothiazideantagoniste de l'aldostéroneMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Telmisartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Tériparatidehormone thyroïdienneMajeure

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (notice Choriogonadotropine alfa, Contre-indications)

  • ThiamazoleantithyroïdienMajeure

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (notice Choriogonadotropine alfa, Contre-indications)

  • Torasémidediurétique de l'anseMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Triamtérènediurétique épargneur de potassiumMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Triamtérène et hydrochlorothiazidediurétique épargneur de potassiumMajeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • Valsartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

Interactions modérées (23)

  • BicalutamideandrogèneModérée

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (notice Choriogonadotropine alfa, Précautions)

  • DanazolandrogèneModérée

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (notice Choriogonadotropine alfa, Précautions)

  • Désogestrel et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Diacétate d'étynodiol et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Drospirénone et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • EstradiolestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Estradiol et diénogestcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Estradiol et noréthistéroneestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Estrogènes conjuguésestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Estrogènes conjugués et bazédoxifèneestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Estrogènes estérifiés et méthyltestostéroneestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Étonogestrel et éthinylestradiolestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • FlutamideandrogèneModérée

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (notice Choriogonadotropine alfa, Précautions)

  • FulvestrantestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Gonadotrophine chorioniqueModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Lévonorgestrel et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • MéthyltestostéroneandrogèneModérée

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (notice Choriogonadotropine alfa, Précautions)

  • Norelgestromine et éthinylestradiolestrogèneModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Noréthistérone et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Norgestimate et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • Norgestrel et éthinylestradiolcontraceptif oralModérée

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (notice Choriogonadotropine alfa, Mises en garde)

  • ProgestéroneprogestatifModérée

    The indices most generally used are as follows: A rise in basal body temperature Increase in serum progesterone and Menstruation following a shift in basal body temperature Urinary or serum luteinizing hormone (LH) rise When used in conjunction with the indices of progesterone production, sonographic visualization of the ovaries will assist in determining if… (notice Choriogonadotropine alfa, Précautions)

  • TestostéroneandrogèneModérée

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (notice Choriogonadotropine alfa, Précautions)

Vérifiez Choriogonadotropine alfa avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.